Acute Care and Pain

Navigate a growing market with confidence

An aging population is driving development in the acute care and pain market. Quintiles' acute care and pain management team applies cross-disciplinary knowledge to help successfully progress your drug from early clinical development through commercialization.

promo_men talking

950 employees who are MDs and 900 employees who are PhDs

All with experience across a number of fields and a particular focus on oncology, cardiovascular, central nervous system and internal medicine.

Address pain, deter abuse and safeguard patients

Pain trial regulations include extensive safety evaluations to determine tolerance levels, withdrawal and rebound effects and assessment of potential abuse, dependence or misuse. At the same time, increased prevalence of conditions such as osteoarthritis, chronic low back pain, diabetic peripheral neuropathic pain and post herpetic neuralgia is driving demand for tolerable and effective analgesics with abuse-deterrent formulations.

Expertise at the ready

Our Acute Care and Pain Center of Excellence houses approximately 650 team members experienced in the acute care and pain management market. They can help you meet safety needs as well as optimize product development potential.

With backgrounds in medical, operations, strategic planning and design, and early through late phase development, they represent a cross-functional team of therapeutic experts ready to take on your challenge.

Our experts can help maximize the possibilities for any type of pain trial, including neuropathic, nocioceptive, acute, chronic, oncologic and palliative care. From pipeline to portfolio to population health, Quintiles has the answers you need.

The power of possibilities

As you take on challenges like developing more effective treatments for neuropathic pain, producing abuse-deterrent opioids or managing intractable severe pain in cancer patients, Quintiles will provide guidance and insight needed to support a better, safer end product.